Phase I data for CC-90001 in healthy subjects and in participants with hepatic impairment July 6, 2021
Identification of a vitamin D3 analogue inducing SREBP degradation without calcemic action July 5, 2021
Lynk cleared to begin clinical trials in China with LNK-01003 for inflammatory bowel disease June 28, 2021
RSS